Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Invacare/Healthdyne

This article was originally published in The Gray Sheet

Executive Summary

Invacare/Healthdyne: Invacare rejects Healthdyne's proposal that it participate in discussions of alternatives to Invacare's unsolicited takeover bid, calling the offer "nothing more than a `sham' designed to win votes in the proxy contest" at Healthdyne's July 30 annual shareholder meeting. Healthdyne issued a statement June 24 saying it would entertain "strategic alternatives" to Invacare's $15-per-share hostile takeover bid. Invacare could participate in the process, Healthdyne said, if it withdrew its offer and agreed to confidentiality and standstill provisions. Invacare announced June 23 that it has extended for the third time its tender offer of $15 per Healthdyne share. The offer, which had been set to expire June 20 ("The Gray Sheet" June 16, In Brief), is now good until Aug. 1, 1997. In a June 25 release, Invacare says Healthdyne's plan does not indicate that it is serious about a transaction. "If Healthdyne's board were serious" about a sale, "it would declare the company for sale to the highest bidder and commence an auction," Invacare says. "The so-called process referred to in Healthdyne's letter falls far short of this"...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008326

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel